OraSure Technologies, Inc. (OQ:OSUR)

Business Focus: Medical Equipment, Supplies & Distribution

Apr 22, 2024 08:00 am ET
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certain business developments for 4:45 p.m. ET on Wednesday, May 8, 2024. A webcast of the conference...
Feb 27, 2024 04:05 pm ET
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services, today announced its financial results for the three months ended...
Feb 13, 2024 04:05 pm ET
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and certain business developments for 5 p.m. ET on Tuesday, Feb. 27, 2024. A webcast of the conference call...
Jan 04, 2024 07:05 am ET
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company 
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced it is leading the Series B financing and has entered...
Nov 13, 2023 04:15 pm ET
OraSure to Participate in Upcoming Investor Conferences
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the company is scheduled to participate in the following...
Nov 07, 2023 04:05 pm ET
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended...
Oct 23, 2023 04:05 pm ET
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2023 financial results and certain business developments for 5:00 pm ET on Tuesday, November 7, 2023. A webcast of the conference...
Aug 03, 2023 04:05 pm ET
OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended June...
Jul 20, 2023 04:05 pm ET
OraSure to Announce Second Quarter 2023 Financial Results and Host Earnings Call on August 3rd
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 second quarter financial results and certain business developments for 5:00 pm ET on Thursday, August 3, 2023. A webcast of the conference...
Jul 20, 2023 07:05 am ET
OraSure Technologies Elects Robert McMahon to the Board of Directors
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today the election of Robert W. McMahon, CMA, MBA, to the...
Jun 13, 2023 04:05 pm ET
Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and at-home diagnostic testing, as well as non-invasive self-sampling technologies and microbiome-focused biocomputational solutions, announced today that a major health...
Jun 01, 2023 10:45 am ET
Thinking about buying stock in OraSure Technologies, Quipt Home Medical, Talkspace, Frontline, or Oncolytics Biotech?
NEW YORK, June 1, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OSUR, QIPT, TALK, FRO, and ONCY.
May 10, 2023 04:05 pm ET
OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended March...
May 03, 2023 07:05 am ET
2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 first quarter financial results and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, May 10, 2023. May 10, 2023...
Feb 14, 2023 04:05 pm ET
OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended...
Feb 07, 2023 07:05 am ET
2022 Fourth Quarter Earnings Conference Call Tuesday, February 14, 2023, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 fourth quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, February 14, 2023. February 14,...
Dec 01, 2022 07:05 am ET
OraSure Technologies Continues its Dedication to Ending the HIV Epidemic
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, will ring the closing bell for the Nasdaq Stock Market this afternoon in honor of World AIDS Day. World AIDS Day is commemorated annually on December 1 to raise...
Nov 14, 2022 07:05 am ET
OraSure Technologies to Present at Stephens Annual Investment Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Ken McGrath, Chief Financial Officer, will participate in a...
Nov 08, 2022 04:05 pm ET
OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended...
Nov 03, 2022 09:15 am ET
OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Company received U.S. FDA clearance for its ORAcollect®•Dx saliva collection device...
Nov 02, 2022 07:05 am ET
InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 Rapid Test is now available in Amazon’s online store to...
Nov 01, 2022 07:05 am ET
2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, November 8, 2022. November 8, 2022...
Sep 28, 2022 08:39 am ET
Thinking about buying stock in Acumen Pharmaceuticals, Prothena Corp, Anavex Life Sciences, Ocugen, or OraSure Technologies?
NEW YORK, Sept. 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ABOS, PRTA, AVXL, OCGN, and OSUR.
Sep 28, 2022 07:05 am ET
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Biomedical Advanced Research and Development Authority (BARDA) has issued the...
Sep 20, 2022 04:05 pm ET
OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Company has been selected to provide its OraQuick® In-Home HIV tests in support of...
Sep 14, 2022 07:05 am ET
OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today a new collaboration between Diversigen, Inc., a subsidiary of OraSure Technologies, and Mars...
Aug 09, 2022 04:05 pm ET
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended June...
Aug 02, 2022 07:05 am ET
OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 second quarter financial results and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Tuesday, August 9, 2022. August 9,...
Jul 28, 2022 07:05 am ET
OraSure’s Ongoing Commitment to End the Hepatitis C Epidemic Heats Up at the Racetrack
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today its ongoing commitment to fight the hepatitis C epidemic. July 28 is commemorated around the...
Jul 14, 2022 07:05 am ET
OraSure Technologies Launches New Product for Microbiome Researchers to Study DNA and RNA
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its OMNIgene®•GUT DNA and RNA product (OMR-205) is now available to gut microbiome...
Jun 08, 2022 04:05 pm ET
OraSure Technologies Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that on June 4, 2022, OraSure’s Board of Directors granted Carrie Eglinton Manner, the...
May 25, 2022 07:05 am ET
InteliSwab® COVID-19 Rapid Test Selected by Federal Government for Nationwide School Testing
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 Rapid Test has been selected by the U.S. Department of Health...
May 23, 2022 04:05 pm ET
Carrie Eglinton Manner Appointed Chief Executive Officer of OraSure
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, today announced that Carrie Eglinton Manner has been appointed President and Chief Executive Officer,...
May 17, 2022 07:05 am ET
InteliSwab® COVID-19 Rapid Test Validated to Detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5 Subvariants
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1, BA.3 and BA.5...
May 10, 2022 04:05 pm ET
OraSure Reports 1Q22 Record Revenue of $67.7 Million; +16% Year-Over-Year With 21% Growth in Non-COVID Revenue
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended March...
May 03, 2022 04:05 pm ET
OraSure Technologies, Inc. 2022 First Quarter Earnings Conference Call Tuesday, May 10, 2022, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 first quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, May 10, 2022. May 10, 2022...
Apr 07, 2022 07:05 am ET
OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today its OMNIgene®·GUT Dx (OMD-200) microbiome collection device, has been granted de novo...
Mar 31, 2022 07:05 am ET
OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its’ Diversigen subsidiary has launched a new service to provide metatranscriptomic...
Mar 22, 2022 04:05 pm ET
OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its Board of Directors (the “Board”) has appointed...
Feb 23, 2022 04:05 pm ET
OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended...
Feb 16, 2022 04:05 pm ET
OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 fourth quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 23, 2022. February 23,...
Jan 31, 2022 07:05 am ET
InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 rapid tests have been authorized by the U.S. Food and Drug...
Jan 25, 2022 07:05 am ET
OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has launched its OraQuick® HIV Self-Test, an oral swab in-home test for HIV-1 and...
Jan 13, 2022 04:05 pm ET
InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab® COVID-19 rapid tests detect the Omicron variant as effectively as they...
Jan 05, 2022 07:05 am ET
OraSure Technologies Announces Actions to Enhance Stockholder Value
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, today announced preliminary Q4 2021 results, organizational changes, and a Board-level review of strategic...
Dec 14, 2021 07:05 am ET
OraSure Technologies Announces 2022 Annual Meeting Date
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2022 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 17, 2022. The record date for the Meeting will be March 27, 2022. Only...
Nov 30, 2021 07:05 am ET
OraSure Technologies Remains Committed to the Global Fight Against HIV 40 Years After the Discovery of the HIV Virus
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, today announced its plans for World AIDS Day. Commemorated annually on December 1, the U.S. Government's theme for this year’s World AIDS Day is “Ending the HIV...
Nov 19, 2021 07:05 am ET
OraSure Technologies to Present at Upcoming Investor Conferences
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a...
Nov 09, 2021 07:05 am ET
OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that after almost 21 years of service to the Company, Jack E. Jerrett is retiring as the...
Nov 08, 2021 07:05 am ET
OraSure Technologies Appoints Two New Members to the Board of Directors
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today the appointment Nancy J. Gagliano, M.D. and Anne C. Whitaker to the Company’s Board of...
Nov 03, 2021 04:05 pm ET
OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended...
Nov 02, 2021 07:05 am ET
U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the EUA for its InteliSwab™ COVID-19 rapid tests has been amended by the U.S. Food and...
Oct 27, 2021 07:05 am ET
OraSure Technologies 2021 Third Quarter Earnings Conference Call Wednesday, November 3, 2021, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 3, 2021. November...
Oct 04, 2021 08:30 am ET
Thinking about buying stock in OpGen, Adverum Biotechnologies, OraSure Technologies, Sonnet BioTherapeutics, or Sio Gene Therapies?
NEW YORK, Oct. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, ADVM, OSUR, SONN, and SIOX.
Oct 04, 2021 07:05 am ET
OraSure Awarded $109 Million Contract from U.S. Department of Defense to Ramp Manufacturing of InteliSwab™ COVID-19 Rapid Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that it has been awarded a $109 million contract from the U.S. Department of Defense (DOD),...
Sep 23, 2021 08:10 am ET
OraSure to Receive up to $13.6 Million from Biomedical Advanced Research Development Authority to Support InteliSwab™ COVID-19 Rapid Test 510(k) Clearance and CLIA Waiver
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Biomedical Advanced Research Development Authority (BARDA), part of the office of...
Sep 20, 2021 06:00 am ET
OraSure Receives $205 Million Procurement Contract for InteliSwab™ from the Defense Logistics Agency to Supply Over-the-Counter (OTC) Kits as Part of National Pandemic Response
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that the Defense Logistics Agency has awarded the Company a procurement contract for its...
Sep 02, 2021 07:00 am ET
OraSure Technologies Announces Resignation of CFO Roberto Cuca and Succession Plan
OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care testing and sample collection technologies, announced that Chief Financial Officer Roberto Cuca has resigned from the Company effective September 17, 2021. The Company has...
Aug 03, 2021 04:05 pm ET
OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended June...
Jul 27, 2021 04:01 pm ET
OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Tuesday, August 3, 2021. August 3, 2021...
Jun 17, 2021 04:05 pm ET
OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in...
Jun 14, 2021 06:00 am ET
OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing
OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it is collaborating with the Will Rodgers Liver Health Foundation to increase awareness around the role Hepatitis C (HCV) plays in chronic liver disease and promoting testing services...
Jun 07, 2021 09:18 am ET
OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use
OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its COVID-19 rapid antigen tests, which the Company is branding as InteliSwab™....
May 28, 2021 07:00 am ET
OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a...
May 18, 2021 07:00 am ET
OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a...
May 17, 2021 07:00 am ET
OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Scott Gleason has been appointed Senior Vice President...
May 12, 2021 06:00 am ET
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021
OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2021 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern (7:00 a.m. Pacific) on Tuesday, May 18, 2021. In...
May 10, 2021 06:00 am ET
Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV
Insignia Federal Group, LLC, along with partners Building Healthy Online Communities (BHOC), Emory University, Keymind (a Division of Axiom Resource Management), and OraSure Technologies, Inc. (NASDAQ: OSUR), was selected by the Centers for Disease...
May 05, 2021 04:00 pm ET
OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months ended March 31, 2021....
Apr 30, 2021 04:01 pm ET
OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 first quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 5, 2021.  May 5,...
Mar 30, 2021 07:00 am ET
OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization
OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its COVID-19 rapid antigen test for both Prescription Home Use,...
Mar 01, 2021 04:15 pm ET
OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three months and year ended...
Feb 24, 2021 04:01 pm ET
OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the...
Feb 18, 2021 06:00 am ET
2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 fourth quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Monday, March 1, 2021.  March 1,...
Jan 29, 2021 06:00 am ET
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its OMNIgene®·ORAL (OM-505) saliva collection kit, a product of...
Jan 28, 2021 06:00 am ET
OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its OMNIgene®·ORAL (OME-505) saliva collection device, a product...
Jan 26, 2021 07:57 am ET
OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Chronomics Limited has selected the OMNIgene®·ORAL (OME-505)...
Jan 25, 2021 06:00 am ET
Leading Microbiome Researcher Dr. Eric Pamer Joins Diversigen’s Scientific Advisory Board
Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), today announced that Eric Pamer, M.D., Professor of Medicine, Section of Infectious Diseases and Global Health and director of the Duchossois Family Institute at the...
Jan 21, 2021 06:00 am ET
OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencing Platform
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its Oragene®•Dx (OGD-610) saliva collection device was...
Jan 08, 2021 06:00 am ET
OraSure Technologies Announces 2021 Annual Meeting Date
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2021 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 18, 2021. The record date for the Meeting will be March 26, 2021. Only...
Jan 05, 2021 06:00 am ET
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the...
Dec 23, 2020 06:00 am ET
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its OMNIgene®·ORAL (OM/OME-505) collection device was...
Dec 21, 2020 04:01 pm ET
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today disclosed that the U.S. Food and Drug Administration (FDA) has requested additional information as part of its review of...
Nov 30, 2020 07:00 am ET
OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in the fight against HIV, today announced its plans to commemorate World AIDS Day. On Tuesday, Dec. 1st, OraSure will ring the closing bell for the NASDAQ Stock Market, in a virtual ceremony that...
Nov 30, 2020 07:00 am ET
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 2020 Evercore ISI...
Nov 12, 2020 07:00 am ET
OraSure Technologies to Present at the Stephens Annual Investment Conference 2020
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the...
Nov 09, 2020 07:02 am ET
Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Consumers
LENEXA, Kan., Nov. 9, 2020 /PRNewswire/ -- Today, Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laboratories in the U.S., announced that it has begun selling its best-in-class CRL Rapid Response™ saliva-based COVID-19 RT-PCR test directly to consumers. At $110 (which includes the cost of prepaid FedEx Priority Overnight shipping in both directions), the easy-to-use, highly accurate test is one of the most affordable COVID-19 home tests currently available in the market and the least expensive at-home saliva test.
Nov 04, 2020 04:01 pm ET
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three- and nine-month periods ended...
Nov 03, 2020 07:00 am ET
OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Device for SARS CoV-2
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its DNA Genotek subsidiary has received Emergency Use...
Oct 21, 2020 06:00 am ET
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call  Wednesday, November 4, 2020, 5:00 p.m. ET
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 third quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, November 4, 2020.  November 4,...
Oct 19, 2020 09:31 am ET
Thinking about buying stock in OraSure Technologies, AMC Entertainment, Can Fite Biopharma, American Airlines, or Canopy Growth Corp?
NEW YORK, Oct. 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OSUR, AMC, CANF, AAL, and CGC.
Oct 19, 2020 06:00 am ET
OraSure’s OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its DNA Genotek subsidiary has received Emergency Use...
Sep 24, 2020 06:00 am ET
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its ORAcollect®·RNA (OR-100) saliva collection device has...
Sep 15, 2020 12:00 pm ET
Former CEO of H2O+ Beauty, Former Chief Chemist of MAC Cosmetics Launch Innovative Skincare Brand Using First-Ever Scientific Microbiome Testing
Today, Joy Chen, former CEO of H2O+ Beauty, and Victor Casale, former Chief Chemist of MAC Cosmetics and co-founder of CoverFX, announced the launch of Pure Culture Beauty, the first skincare brand using data and science to deliver a comprehensive,...
Sep 03, 2020 04:30 pm ET
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its ORAcollect®·RNA (OR-100) collection device was included...
Aug 27, 2020 04:30 pm ET
OraSure Technologies to Present at Upcoming Investor Conferences
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the...
Aug 05, 2020 04:01 pm ET
OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing Programs
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its financial results for the three and six months ended June 30,...
Jul 31, 2020 12:15 pm ET
OraSure’s OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its OMNIgene®·ORAL (OM-505) saliva collection device is...
Jul 31, 2020 11:23 am ET
Clinical Reference Laboratory Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test
LENEXA, Kan., July 31, 2020 /PRNewswire/ -- Today, Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laboratories in the U.S., announced that it received FDA Emergency Use Authorization (EUA) and is scaling up capacity for CRL Rapid Response™, a saliva-based COVID-19 RT-PCR test that can be self-collected at home, work or any other setting. The test, shown in CRL's EUA studies to be more sensitive and accurate than the standard COVID-19 anterior nasal swab test, detects the presence of coronavirus in the saliva of the test taker. In addition, the test is
Jul 22, 2020 06:00 am ET
OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 second quarter financial results and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, August 5, 2020.  August 5, 2020...
Jun 25, 2020 08:00 am ET
Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study
Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe...
Jun 17, 2020 07:00 am ET
OraSure’s DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for Metabolomics
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services is introducing the first and only commercially available device for in-home,...
Jun 17, 2020 07:00 am ET
Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for Metabolomics
MORRISVILLE, N.C., June 17, 2020 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics, and DNA Genotek, a subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), have collaborated to bring OMNImet™·GUT, the first device for in-home collection and ambient-temperature storage and shipping of fecal samples for metabolomics, to the research market.
Jun 10, 2020 08:00 am ET
OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid Samples
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced it has been awarded a $629,217 contract from the Biomedical...
Jun 08, 2020 08:00 am ET
OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today that Phosphorus Diagnostics, a leader in diagnostic and...
Jun 03, 2020 08:50 pm ET
OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common Stock
OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced the full exercise by the underwriters of their option to purchase an additional 1,200,000 shares of its common stock in connection with the Company’s previously...
Jun 02, 2020 11:15 pm ET
OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock
OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced the pricing of an underwritten offering of 8,000,000 shares of its common stock at a price of $11.00 per share. After the underwriting discount and estimated...
Jun 01, 2020 04:01 pm ET
OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock
OraSure Technologies, Inc. (Nasdaq: OSUR) (“OraSure” or the “Company”) today announced it has commenced an underwritten public offering of 8,000,000 shares of its common stock. J.P. Morgan Securities LLC, Citigroup Global Markets Inc. and Evercore...
May 29, 2020 07:00 am ET
OraSure Technologies, Inc. Announces Purchase of UrSure, Inc.
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, and microbiome laboratory and analytical services, today announced that it has entered into a definitive...
May 29, 2020 06:00 am ET
OraSure Technologies Appoints Lelio Marmora to Board of Directors
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the appointment of Lelio Marmora as a member of the Company’s...
May 26, 2020 06:00 am ET
OraSure Technologies to Present at the Jefferies 2020 Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, Ph.D., President and CEO, will speak...
May 22, 2020 09:31 am ET
Thinking about trading stocks or options in Burlington Stores, Floor & Decor Holdings, Sea Ltd, OraSure Technologies, or American Airlines Group?
NEW YORK, May 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BURL, FND, SE, OSUR, and AAL.
May 22, 2020 07:00 am ET
OraSure’s OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, (NASDAQ: OSUR), announced today that its OMNIgene®·ORAL saliva collection device...
May 22, 2020 06:00 am ET
Diversigen Inc. Selected by Nom Nom™ as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services
Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ: OSUR), and Nom Nom™, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome...
May 15, 2020 06:00 am ET
OraSure Technologies to Present at the UBS Virtual Global Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the UBS Virtual Global...
May 14, 2020 06:00 am ET
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 19, 2020
OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2020 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 19, 2020. In order to...
May 12, 2020 08:00 am ET
OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its Diversigen and CoreBiome subsidiaries have combined their...
May 11, 2020 09:31 am ET
Thinking about buying stock in AMC Entertainment, Carnival Corp, OraSure Technologies, Inovio Pharmaceuticals, or Aytu Bioscience?
NEW YORK, May 11, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, CCL, OSUR, INO, and AYTU.
May 06, 2020 04:00 pm ET
OraSure Announces 2020 First Quarter Financial Results and Provides COVID-19 Update
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced its financial results for the three months ended March 31, 2020...
May 05, 2020 06:00 am ET
OraSure Technologies Appoints Lisa Nibauer as Infectious Disease Business Unit Lead
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Lisa Nibauer has been appointed Executive Vice President,...
May 04, 2020 06:00 am ET
DNA Genotek’s ORAcollect®·RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that its ORAcollect®·RNA kit (OR-100) was included as the collection...
Apr 09, 2020 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2020 first quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May...
Apr 08, 2020 06:00 am ET
OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the appointment of David J. Shulkin, M.D., as a member of the...
Apr 06, 2020 06:00 am ET
OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced it has been awarded a $710,310 contract from the Biomedical...
Feb 26, 2020 06:00 am ET
OraSure Technologies to Present at the Raymond James 41st Annual Institutional Investors Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Raymond James 41st...
Feb 19, 2020 04:00 pm ET
OraSure Announces 2019 Full Year and Fourth Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced its financial results for the three months and year ended December...
Jan 29, 2020 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2019 fourth quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday,...
Jan 22, 2020 06:00 am ET
DNA Genotek Announces FDA General Use Clearance for Oragene®·Dx Family of Products
DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that the U.S. Food and Drug Administration (FDA) has granted a...
Jan 08, 2020 06:00 am ET
OraSure Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 38TH Annual J.P....
Dec 17, 2019 06:00 am ET
OraSure Technologies Announces 2020 Annual Meeting Date
OraSure Technologies, Inc. (NASDAQ:  OSUR) today announced that its 2020 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 19, 2020.  The record date for the Meeting will be March 27, 2020....
Nov 26, 2019 08:00 am ET
OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Opening Bell
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in the fight against HIV, today announced its plans to commemorate World AIDS Day. On Monday, Dec. 2nd, OraSure will ring the opening bell for the NASDAQ Stock Market. The bell ringing ceremony...
Nov 26, 2019 06:00 am ET
OraSure Technologies to Present at the Piper Jaffray 31st Annual Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Piper Jaffray 31st...
Nov 06, 2019 04:05 pm ET
OraSure Announces 2019 Third Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the three and nine months ended September 30, 2019. Financial and Business...
Nov 06, 2019 04:00 pm ET
OraSure Technologies, Inc. Announces Purchase of Diversigen
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today announced that it has entered into a definitive agreement to acquire the outstanding equity of Diversigen...
Nov 06, 2019 06:00 am ET
OraSure Technologies to Present at Stephens 2019 Nashville Investment Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, and Mr. Roberto Cuca, Chief Financial Officer will host a fireside...
Oct 28, 2019 06:00 am ET
OraSure Technologies Announces Support for New Federal Oral Fluid Drug Testing Guidelines
The Substance Abuse and Mental Health Services Administration (SAMHSA) has published new guidelines, permitting oral fluid drug testing in federally regulated markets. SAMHSA is the agency within the U.S. Department of Health and Human Services...
Oct 22, 2019 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2019 third quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday,...
Aug 19, 2019 08:00 am ET
OraSure Announces Sale of Cryosurgical Systems Business
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced the sale of its cryosurgical systems business to CryoConcepts, LP for an aggregate purchase price of $12 million...
Aug 14, 2019 09:00 am ET
Orasure Technologies Appoints James a. Datin to Its Board of Directors
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of James A. Datin, as a member of the Company’s Board of Directors.  Mr. Datin will serve as a...
Aug 06, 2019 04:00 pm ET
OraSure Announces 2019 Second Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the three and six months ended June 30, 2019. “Second...
Jul 31, 2019 06:00 am ET
Orasure Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 39th Annual Canaccord...
Jul 25, 2019 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2019 second quarter financial results, updated financial guidance and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Tuesday,...
Jun 26, 2019 05:00 pm ET
OraSure Technologies and Others Join Forces for HIV Testing Day
National HIV Testing Day will be commemorated on June 27 across the nation with efforts to raise awareness of HIV and encourage people to get tested and know their HIV status. OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care...
Jun 14, 2019 04:00 pm ET
UPDATE - OraSure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference   
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Roberto Cuca, Chief Financial Officer, will speak to the investment community at the Raymond James Life...
Jun 13, 2019 06:00 am ET
Orasure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Mr. Roberto Cuca, Chief Financial Officer, will speak to the investment community at the Raymond James Life...
May 29, 2019 06:00 am ET
OraSure Technologies to Present at Jefferies 2019 Healthcare Conference  
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Jefferies 2019...
May 15, 2019 06:00 am ET
OraSure Technologies to Present at UBS Global Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the UBS Global Healthcare...
May 14, 2019 06:00 am ET
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 21, 2019
OraSure Technologies, Inc. (NASDAQ: OSUR), announced that its 2019 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019. In order to...
May 08, 2019 04:00 pm ET
OraSure Announces 2019 First Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the quarter ended March 31, 2019. “Our first quarter 2019 performance was in line...
May 08, 2019 01:30 pm ET
CryoConcepts Receives FDA Clearance on Two Cryosurgical Devices for the Physician Office Market
BETHLEHEM, Pa., May 8, 2019 /PRNewswire/ -- CryoConcepts, LP, a market leader in the development and manufacture of cryosurgical products, announced today they have received FDA clearance on two new, patent pending, cryosurgical devices for the physician's office market.   
Apr 25, 2019 08:00 am ET
CoreBiome Announces Leading Microbiome Researcher Rob Knight as Scientific Advisor
CoreBiome, a microbiome discovery services provider and wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that Rob Knight, Professor and Director of the Center for Microbiome Innovation at the University of California San Diego, has joined its scientific advisory board.
Apr 18, 2019 07:55 am ET
Market Trends Toward New Normal in GrafTech International, Avinger, OraSure Technologies, Adamis Pharmaceuticals, Crinetics Pharmaceuticals, and Wayside Technology Group — Emerging Consolidated Expect
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of GrafTech International Ltd. (NYSE:EAF), Avinger, Inc. (NASDAQ:AVGR),...
Apr 17, 2019 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2019 first quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May...
Feb 27, 2019 06:00 am ET
OraSure Technologies to Present at the Raymond James 40th Annual Institutional Investors Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the Raymond James 40th...
Feb 06, 2019 04:00 pm ET
OraSure Announces 2018 Full Year and Fourth Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the full year and fourth quarter of 2018. Financial Highlights Net revenues...
Jan 15, 2019 07:35 am ET
Research Report Identifies Herc, Genesee & Wyoming, OraSure Technologies, Microchip Technology, Ion Geophysical, and OMNOVA Solutions with Renewed Outlook — Fundamental Analysis, Calculating Forward M
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Herc Holdings Inc. (NYSE:HRI), Genesee & Wyoming, Inc. (NYSE:GWR),...
Jan 10, 2019 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2018 fourth quarter financial results, 2019 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on...
Jan 04, 2019 07:00 am ET
OraSure Technologies, Inc. Announces Two Acquisitions and Reaffirms Fourth Quarter 2018 Guidance
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today announced that it has entered into definitive agreements to acquire two companies. The transactions are...
Jan 02, 2019 09:43 am ET
OraSure Technologies, Inc.: Updated Release to Clarify Timing of Presentation
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 37TH Annual J.P....
Jan 02, 2019 06:00 am ET
OraSure Technologies to Present at the 37th Annual J.P. Morgan Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 37TH Annual J.P....
Dec 10, 2018 06:00 am ET
OraSure Technologies Announces 2019 Annual Meeting Date
OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2019 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 21, 2019.  This will be a completely virtual meeting, conducted as a...
Nov 29, 2018 08:33 am ET
OraSure Technologies to Ring NASDAQ Stock Market Opening Bell in Honor of World AIDS Day
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will ring the NASDAQ stock market opening bell on Monday,...
Nov 28, 2018 08:35 am ET
Research Report Identifies OraSure Technologies, Sierra Wireless, Seres Therapeutics, Lydall, ChromaDex, and Capricor Therapeutics with Renewed Outlook — Fundamental Analysis, Calculating Forward Move
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of OraSure Technologies, Inc. (NASDAQ:OSUR), Sierra Wireless, Inc....
Nov 21, 2018 06:00 am ET
OraSure Technologies to Present at the 30th Annual Piper Jaffray Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the 30TH Annual Piper...
Nov 08, 2018 06:00 am ET
OraSure Technologies to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Canaccord Genuity...
Nov 07, 2018 04:00 pm ET
OraSure Announces 2018 Third Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the three and nine months ended September 30, 2018. Financial Highlights Net revenues...
Oct 18, 2018 08:20 am ET
Consolidated Research: 2018 Summary Expectations for Barnes & Noble, Boot Barn, Endologix, Pilgrim's Pride, OraSure Technologies, and Genesco — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Barnes Noble, Inc. (NYSE:BKS), Boot Barn Holdings, Inc. (NYSE:BOOT),...
Oct 08, 2018 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2018 third quarter financial results, 2018 fourth quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on...
Sep 26, 2018 06:00 am ET
OraSure Technologies to Present at the Cantor Global Healthcare Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, Ph.D., President and CEO, will speak to the investment community at the Cantor Global...
Sep 06, 2018 06:00 am ET
OraSure Technologies to Present at the CL King 16th Annual Best Ideas Conference
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President and CEO, will speak to the investment community at the CL King 16th Annual Best...
Aug 24, 2018 08:25 am ET
Report: Exploring Fundamental Drivers Behind HomeStreet, Schnitzer Steel Industries, OraSure Technologies, Genomic Health, Benchmark Electronics, and Stoneridge — New Horizons, Emerging Trends, and Up
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of HomeStreet, Inc. (NASDAQ:HMST), Schnitzer Steel Industries, Inc....
Aug 08, 2018 04:05 pm ET
OraSure Announces 2018 Second Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2018. Financial Highlights...
Jul 23, 2018 08:34 am ET
OraSure Technologies, Inc. Appoints Vice President, Corporate Communications
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostics and specimen collection devices, today announced that Jeanne Mell has been appointed as the Company’s new Vice President, Corporate Communications. Ms. Mell will join...
Jul 19, 2018 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2018 second quarter financial results, 2018 third quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on...
Jun 19, 2018 07:35 am ET
New Research Coverage Highlights Sensient Technologies, OraSure Technologies, Gentex, Anixter International, NorthStar Realty Europe, and Great Plains Energy — Consolidated Revenues, Company Growth, a
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sensient Technologies Corporation (NYSE:SXT), OraSure Technologies, Inc....
May 30, 2018 06:00 am ET
OraSure Technologies to Present at Jefferies Global Healthcare Conference
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President and CEO, will speak to the investment community at Jefferies Global Healthcare...
May 14, 2018 06:00 am ET
OraSure Technologies to Present at the UBS Global Healthcare Conference   
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President and CEO, will speak to the investment community at the UBS Global Healthcare...
May 04, 2018 06:00 am ET
OraSure Technologies Appoints New Chief Financial Officer
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Roberto Cuca has been appointed as the Company’s new Chief Financial Officer, effective as of June 8, 2018....
May 02, 2018 04:00 pm ET
OraSure Announces 2018 First Quarter Financial Results
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the quarter ended March 31, 2018. Financial Highlights Consolidated net...
May 01, 2018 06:00 am ET
OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
BETHLEHEM, Pa., May 01, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2018 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00...
Apr 24, 2018 07:50 am ET
Market Trends Toward New Normal in Healthways, Global Net Lease, OraSure Technologies, Lions Gate Entertainment, Francesca's, and Barnes Group — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Healthways, Inc. (NASDAQ:TVTY), Global Net Lease,...
Apr 11, 2018 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
2018 First Quarter Earnings Conference CallWednesday, May 2, 2018, 5:00 p.m. ET
Apr 10, 2018 04:05 pm ET
OraSure Technologies Appoints New Senior Vice President, Business Development
BETHLEHEM, Pa., April 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that David Rappaport has been appointed as the Company’s new Senior Vice...
Mar 01, 2018 07:35 am ET
Analysis: Positioning to Benefit within Penumbra, Qualys, OraSure Technologies, Air Lease, Aduro Biotech, and Progenics Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Penumbra, Inc. (NYSE:PEN), Qualys, Inc. (NASDAQ:QLYS),...
Feb 26, 2018 06:00 am ET
OraSure Technologies to Present at the Raymond James 39th Annual Institutional Investors Conference
BETHLEHEM, Pa., Feb. 26, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment...
Feb 08, 2018 06:00 am ET
OraSure Technologies to Present at the LEERINK 7th Annual Global Healthcare Conference
BETHLEHEM, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment...
Feb 07, 2018 04:00 pm ET
OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
BETHLEHEM, Pa., Feb. 07, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the fourth quarter and full-year ended December 31, 2017.
Feb 07, 2018 01:15 pm ET
OraSure Technologies, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 7, 2018 / OraSure Technologies, Inc. (NASDAQ: OSUR) will be discussing their earnings results in their Q4 Earnings Call to be held on February 7, 2018 at 5:00 PM Eastern Time.
Feb 02, 2018 06:00 am ET
OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors
BETHLEHEM, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Dr. Aradhana Sarin, as a member of the Company's...
Jan 30, 2018 02:56 pm ET
Philadelphia Investment Forum Scoops the Groundhog – Delivers the Forecast a Day Early
While the world’s attention turns to Pennsylvania on February 2nd for Groundhog Day prognostications about winter weather, investment professionals will gather in Philadelphia a day early on February 1st for the 2018 Emerald Asset Management Groundhog Day Investment Forum. The Forum is the unofficial kick-off to the year ahead as Emerald’s team of analysts and portfolio managers present their strategic investment themes and trends for 2018, focusing on key sectors such as Banking & Finance, Consumer, Energy, Industrials, Li
Jan 17, 2018 10:56 am ET
2018 OUTLOOK AND INSIGHTS: Investment Trends and Themes to be Highlighted at the Emerald Groundhog Day Investment Forum
Join Emerald Asset Management for the landmark 25th annual Emerald Groundhog Day Investment Forum on February 1st in Philadelphia. The Forum is the unofficial kick-off to the year ahead as Emerald’s team of analysts and portfolio managers present their key investment themes and trends for 2018, focusing on these key sectors:
Jan 17, 2018 06:00 am ET
OraSure Technologies Earnings Conference Call Invitation
2017 Fourth Quarter Earnings Conference Call Wednesday, February 7, 2018, 5:00 p.m. ET
Jan 05, 2018 06:00 am ET
OraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference
BETHLEHEM, Pa., Jan. 05, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment...
Jan 04, 2018 06:00 am ET
OraSure Technologies Announces Management Succession Plan
Company Also Increases Revenue Forecast for Q4 2017
Jan 03, 2018 11:16 am ET
UPDATE – Recro Pharma Announces Key Executive Promotions to the Financial Team
MALVERN, Pa., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today announced several key promotions to its executive leadership...
Jan 03, 2018 08:15 am ET
Investor Expectations to Drive Momentum within OraSure Technologies, Air Lease, Buckeye Partners, Glatfelter, Great Western, and Trustmark — Discovering Underlying Factors of Influence
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of OraSure Technologies, Inc. (NASDAQ:OSUR), Air Lease...
Dec 08, 2017 06:00 am ET
OraSure Technologies Announces 2018 Annual Meeting Date
BETHLEHEM, Pa., Dec. 08, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2018 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on Tuesday, May 8, 2018. ...
Nov 30, 2017 08:41 am ET
OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing
BETHLEHEM, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced several new HIV testing-related initiatives, in recognition of World AIDS Day.  OraSure is...
Nov 02, 2017 06:00 am ET
OraSure Technologies to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
BETHLEHEM, Pa., Nov. 02, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.